ABGX Abgenix (MM)

Abgenix to Present at the Smith Barney Citigroup 2005 Healthcare Conference FREMONT, Calif., March 23 /PRNewswire-FirstCall/ -- Abgenix, Inc. (NASDAQ:ABGX) today announced that it will present at the Smith Barney Citigroup 2005 Healthcare Conference on Wednesday, March 30, 2005 at 6:45 a.m. PT / 9:45 a.m. ET. The presentation will be webcast live and may be accessed by visiting the Abgenix website at http://www.abgenix.com/. A replay of the webcast will also be available on the company's website until Wednesday, April 13, 2005. Dr. Gisela Schwab, chief medical officer of Abgenix, will provide an update on the company's antibody drug development activities. About Abgenix Abgenix is a biopharmaceutical company focused on the discovery, development and manufacturing of human therapeutic antibodies. The company's antibody development platform includes a leading technology and state-of-the-art manufacturing capabilities that enable the rapid generation, selection and production of high affinity, fully human antibody product candidates to a variety of disease targets. Abgenix leverages its leadership position in human antibody technology to build a diversified product portfolio through the establishment of collaborations with multiple pharmaceutical and biotechnology companies. For more information on Abgenix, visit the company's website at http://www.abgenix.com/. DATASOURCE: Abgenix, Inc. CONTACT: Ami Knoefler, Senior Director, Corporate Communications and Investor Relations of Abgenix, Inc., +1-510-284-6350, or +1-510-284-6605 Web site: http://www.abgenix.com/

Copyright